Niraparib tosylate monohydrate is a salt-hydrate form of the active pharmaceutical ingredient niraparib. It is a PARP inhibitor used as a pharmaceutical raw material in the manufacturing of anticancer medications.
内容范围: 本页信息面向化学品识别与工业供应、研发、生产场景,不构成疗效宣称、医疗建议或药品使用指导。
Niraparib
医药原料
Ceftolozane and tazobactam
医药原料
5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine
医药原料
[2-(3-Hydroxyphenyl)cyclohex-1-enyl]-N,N-dimethylmethanamine Hydrochloride
医药原料
2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
医药原料
Niraparib tosylate monohydrate(CAS 1613220-15-7)的国际 HS 编码为 2933.39。
2933.39
2933 39 99
归类依据欧盟海关化学品目录 ECICS(2026-07 快照,HS 2022 版)。各国税则细目及产品形态可能影响最终归类。
4-methylbenzenesulfonic acid;2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide;hydrate
ACNPUCQQZDAPJH-FMOMHUKBSA-N
CC1=CC=C(C=C1)S(=O)(=O)O.C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N.O